| Product NDC: | 64980-177 |
| Proprietary Name: | Chloroquine Phosphate |
| Non Proprietary Name: | Chloroquine Phosphate |
| Active Ingredient(s): | 250 mg/1 & nbsp; Chloroquine Phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64980-177 |
| Labeler Name: | Rising Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091621 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110701 |
| Package NDC: | 64980-177-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE, PLASTIC (64980-177-10) |
| NDC Code | 64980-177-10 |
| Proprietary Name | Chloroquine Phosphate |
| Package Description | 1000 TABLET in 1 BOTTLE, PLASTIC (64980-177-10) |
| Product NDC | 64980-177 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chloroquine Phosphate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110701 |
| Marketing Category Name | ANDA |
| Labeler Name | Rising Pharmaceuticals, Inc. |
| Substance Name | CHLOROQUINE PHOSPHATE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimalarial [EPC] |